SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029333
Filing Date
2019-08-06
Accepted
2019-08-06 16:07:28
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fate-10q_20190630.htm 10-Q 1895292
2 EX-31.1 fate-ex311_7.htm EX-31.1 9830
3 EX-32.1 fate-ex321_6.htm EX-32.1 4871
  Complete submission text file 0001564590-19-029333.txt   7885725

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fate-20190630.xml EX-101.INS 1964990
5 XBRL TAXONOMY EXTENSION SCHEMA fate-20190630.xsd EX-101.SCH 56451
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20190630_cal.xml EX-101.CAL 51433
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20190630_def.xml EX-101.DEF 194336
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20190630_lab.xml EX-101.LAB 444800
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20190630_pre.xml EX-101.PRE 333665
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 191002116
SIC: 2836 Biological Products, (No Diagnostic Substances)